94
47. Mathews AT, Famodu OA, Olfert MD, Murray PJ, Cuff CF, Downes MT, et al. Efficacy of
nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot
study. Physiol Rep. 2017;5(13):e13329.
48. Laganà AS, Rossetti P, Buscema M, La Vignera S, Condorelli RA, Gullo G, et al. Metabolism
and ovarian function in PCOS women: a therapeutic approach with inositols. Int J Endocrinol.
2016;2016:6306410.
49. Lath R, Shendye R, Jibhkate A. Insulin resistance and lipid profile in polycystic ovary syndrome. Asian J Biomed Pharm Sci. 2015;5(47):30.
50. Whigham DL, Butz ED, Dashti H, Tonelli M, Johnson KL, Cook EM, et al. Metabolic evidence
of diminished lipid oxidation in women with polycystic ovary syndrome. Curr Metabolomics.
2013;1(4):269–78.
51. Li S, Chu Q, Ma J, Sun Y, Tao T, Huang R, et al. Discovery of novel lipid profiles in PCOS: do
insulin and androgen oppositely regulate bioactive lipid production? J Clin Endocrinol Metab.
2016;102(3):810–21.
52. Chandrasekaran S, Sagili H. Metabolic syndrome in women with polycystic ovary syndrome.
Obstet Gynaecol. 2018;20(4):245–52.
53. Liu Q, Xie Y-J, Qu L-H, Zhang M-X, Mo Z-C. Dyslipidemia involvement in the development
of polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2019;58(4):447–53.
54. Pundir J, Charles D, Sabatini L, Hiam D, Jitpiriyaroj S, Teede H, et al. Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome.
Hum Reprod Update. 2019;25(2):243–56.
55. Shamim A, Mahmood T, Ahsan F, Kumar A, Bagga P. Lipids: An insight into the neurodegenerative disorders. Clin Nutr Exp. 2018;20:1–19.
56. Noronha S, Lima P, Campos G, Chírico M, Abreu A, Figueiredo A, et al. Association of highfat diet with neuroinflammation, anxiety-like defensive behavioral responses, and altered thermoregulatory responses in male rats. Brain Behav Immun. 2019;80:500–11.
57. Guillemot-Legris O, Muccioli GG. Obesity-induced neuroinflammation: beyond the hypothalamus. Trends Neurosci. 2017;40(4):237–53.
58. Radtke FA, Chapman G, Hall J, Syed YA. Modulating neuroinflammation to treat neuropsychiatric disorders. BioMed Res Int. 2017;2017:5071786.
59. Joffre C. Polyunsaturated fatty acid metabolism in the brain and brain cells. Feed your mindhow does nutrition modulate brain function throughout life? IntechOpen; 2019.
60. Orio L, Alen F, Pavón FJ, Serrano A, García-Bueno B. Oleoylethanolamide, neuroinflammation and alcohol abuse. Front Mol Neurosci. 2018;11:490.
K. Haider et al.
47. Mathews AT, Famodu OA, Olfert MD, Murray PJ, Cuff CF, Downes MT, et al. Efficacy of
nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot
study. Physiol Rep. 2017;5(13):e13329.
48. Laganà AS, Rossetti P, Buscema M, La Vignera S, Condorelli RA, Gullo G, et al. Metabolism
and ovarian function in PCOS women: a therapeutic approach with inositols. Int J Endocrinol.
2016;2016:6306410.
49. Lath R, Shendye R, Jibhkate A. Insulin resistance and lipid profile in polycystic ovary syndrome. Asian J Biomed Pharm Sci. 2015;5(47):30.
50. Whigham DL, Butz ED, Dashti H, Tonelli M, Johnson KL, Cook EM, et al. Metabolic evidence
of diminished lipid oxidation in women with polycystic ovary syndrome. Curr Metabolomics.
2013;1(4):269–78.
51. Li S, Chu Q, Ma J, Sun Y, Tao T, Huang R, et al. Discovery of novel lipid profiles in PCOS: do
insulin and androgen oppositely regulate bioactive lipid production? J Clin Endocrinol Metab.
2016;102(3):810–21.
52. Chandrasekaran S, Sagili H. Metabolic syndrome in women with polycystic ovary syndrome.
Obstet Gynaecol. 2018;20(4):245–52.
53. Liu Q, Xie Y-J, Qu L-H, Zhang M-X, Mo Z-C. Dyslipidemia involvement in the development
of polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2019;58(4):447–53.
54. Pundir J, Charles D, Sabatini L, Hiam D, Jitpiriyaroj S, Teede H, et al. Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome.
Hum Reprod Update. 2019;25(2):243–56.
55. Shamim A, Mahmood T, Ahsan F, Kumar A, Bagga P. Lipids: An insight into the neurodegenerative disorders. Clin Nutr Exp. 2018;20:1–19.
56. Noronha S, Lima P, Campos G, Chírico M, Abreu A, Figueiredo A, et al. Association of highfat diet with neuroinflammation, anxiety-like defensive behavioral responses, and altered thermoregulatory responses in male rats. Brain Behav Immun. 2019;80:500–11.
57. Guillemot-Legris O, Muccioli GG. Obesity-induced neuroinflammation: beyond the hypothalamus. Trends Neurosci. 2017;40(4):237–53.
58. Radtke FA, Chapman G, Hall J, Syed YA. Modulating neuroinflammation to treat neuropsychiatric disorders. BioMed Res Int. 2017;2017:5071786.
59. Joffre C. Polyunsaturated fatty acid metabolism in the brain and brain cells. Feed your mindhow does nutrition modulate brain function throughout life? IntechOpen; 2019.
60. Orio L, Alen F, Pavón FJ, Serrano A, García-Bueno B. Oleoylethanolamide, neuroinflammation and alcohol abuse. Front Mol Neurosci. 2018;11:490.
K. Haider et al.